The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation ... the strategy to inhibit the enzyme has been explored. Several DPP-4 inhibitors are in clinical development; these are ...

A total of 20,146 patients with nephrolithiasis and type 2 diabetes, including those with gout at baseline, initiated an SGLT ...

"In the emulated clinical trial, the use of SGLT2 inhibitors compared to DPP4 inhibits was linked to significantly lower ...

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

A study published in the American Journal of Ophthalmology suggests that the use of SGLT2 inhibitors in diabetes is linked to ...

The following is a summary of “Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes,” ...

The DPP-4 inhibitors represent the first oral therapies targeted at increasing endogenous incretin levels. As the name suggests, these agents function by inhibiting the essential enzyme DPP-4 ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

dipeptidyl-peptidase-4 inhibitors (DPP-4i), and other GLP-1RAs (which mimic the effects of GLP-1s). Patients prescribed semaglutide had a 40% to 70% reduced risk of first-time Alzheimer’s ...

For each of these groups, they conducted seven target trials comparing semaglutide with insulins, metformin, dipeptidyl-peptidase-4 inhibitors, sodium-glucose cotransporter-2 inhibitors ...